Achim Rothe
Koeln, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Vulnerability to Infections and Secondary Immunodeficiencies in Patients with Non-Hodgkin's Lymphomas Starting Anti-CD20 Antibody-Containing Therapies.
Journal: Oncology research and treatment
Published: August 18, 2025
Targeted therapy for non-small cell lung cancer (NSCLC) in a real-world setting: A single practice experience.
Journal: Cancer treatment and research communications
Published: October 11, 2024
Humoral immune response as an indicator for protection against Covid-19 after anti-SARS-COV2-booster vaccination in hematological and oncological patients.
Journal: International journal of cancer
Published: February 10, 2024
Bridging antifungal prophylaxis with 50 mg or 100 mg micafungin in allogeneic stem cell transplantation: A retrospective analysis.
Journal: European journal of haematology
Published: November 06, 2019
A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma.
Journal: Blood
Published: November 28, 2014
Molecular characterization of the rare translocation t(3;10)(q26;q21) in an acute myeloid leukemia patient.
Journal: Molecular cytogenetics
Published: May 27, 2014
Multi-specific antibodies for cancer immunotherapy.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: March 19, 2014
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group.
Journal: Blood
Published: January 31, 2014
CD30-targeted therapy with brentuximab vedotin and DLI in a patient with T-cell posttransplantation lymphoma: induction of clinical remission and cellular immunity.
Journal: Transplantation
Published: August 07, 2013
18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma.
Journal: Leukemia & lymphoma
Published: June 29, 2013
ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 20, 2013
Last Updated: 09/26/2026